Study of low-dose ketamine for sickle cell pain crisis
Part of Blood & lymphatic, Brain & nervous system, Genetic & congenital clinical trials.
This study tests whether a low-dose of ketamine (a pain medicine) can help children and young adults with sickle cell disease who are in a pain crisis. It aims to provide better pain relief while avoiding some side effects of standard painkillers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 20 years old
- You have sickle cell disease (not just trait)
- You are in a pain crisis that needs IV pain medicine
- You speak English or Spanish
- You have not had a bad reaction to ketamine before
- You do not have serious health problems like uncontrolled high blood pressure, heart disease, liver or kidney disease, or certain mental health conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a low dose of ketamine can help relieve pain for people with sickle cell disease who come to the emergency room with a pain crisis. It aims to find a better way to manage pain during these episodes.
This trial tests when to start ketamine for children and teens with sickle cell disease who are in pain. It aims to find the best timing to help reduce pain in the emergency room or infusion clinic.
This trial tests if adding lidocaine to standard pain treatment can reduce the amount of morphine or oxycodone needed for a severe pain crisis or acute chest syndrome in sickle cell disease. It is for adults in the ICU who have already started opioid treatment within the last 72 hours.
This trial tests if an intravenous medication called L-citrulline can help treat pain crises in children and young adults with sickle cell disease. Participants receive either the study drug or a placebo while in the hospital for a severe pain episode.
This trial tests an IV medication called L-citrulline for children, teens, and young adults (ages 6–21) with sickle cell disease who are having a sudden, severe pain crisis (called a vaso-occlusive crisis). The goal is to see if it helps relieve pain quickly.
This trial tests whether adding acupuncture to standard pain treatments can help manage pain in people with sickle cell disease. It involves brain scans, questionnaires, and acupuncture sessions to see if this approach reduces pain and improves quality of life.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.